India’s pharmaceutical industry has always played an important role in keeping the world healthy. And in May 2025, this sector again showed its strength. According to Pharmaceuticals Export Promotion Council of India (Pharmexcil), India exported $4,961.71 million worth of pharmaceutical goods during April–May 2025. This is a 7.38% growth compared to the same time last year.
India is not only referred to as the Pharmacy of the World, but it is also emerging as a savvy, modish and environmental friendly pharmaceutical powerhouse. Larger targets are now achievable such as a trade of a trillion dollars, and India is striding to achieve it through enhanced manufacturing, improved alliances, and quicker digital services.
What Are India’s Pharma Export Highlights for May 2025?
Here’s how India’s pharma exports looked during this period:
✅ Formulations and biologicals: These ready-made medicines and advanced products made up about 75.74% of all exports.
✅ Bulk drugs and drug intermediates: These are the raw materials used to make medicines. They grew by 4.40% compared to last year.
✅ Vaccines: India exported vaccines worth $190.13 million, showing a huge growth of 13.64%.
✅ Surgical goods: These grew by 8.58%, reaching $124.62 million in exports.
✅ Ayush and herbal products: These products, made from traditional Indian herbs, grew by 7.36% with exports of $119.89 million.
✅ Top regions: Our main markets were NAFTA, Europe, Africa, and LAC, together covering 76% of total pharma exports.
✅ New markets: The ASEAN region contributed 4.88%, showing that India is expanding into new countries.
✅ Top 5 countries: USA, UK, Brazil, South Africa, and France.
✅ Exports to USA: The USA alone bought 34.50% of our medicines, worth $1711.75 million, which was 1.50% more than last year.
✅ Europe and Africa: Exports grew by 3.14% and 1.71% respectively.
How Is India Making Pharma Exports Better?
India’s pharma industry is working on more than just selling medicines. It is trying to do business in a way that is good for people, the environment, and the economy. Here’s how:
1️⃣ Sustainable Manufacturing
Companies like DM Pharma Global are using safer, cleaner, and eco-friendly methods to make medicines. They focus on reducing waste, saving energy, and using green technology.
Many partners trust DM Pharma Global as a monopoly medicine company in India because it offers exclusive rights to sell certain medicines. This helps in fair business growth and makes medicines available where they are most needed.
2️⃣ Digital Transformation
Technology is helping pharma companies work faster and smarter. By using online tools and digital platforms, companies can now handle documents, track shipments, and get approvals much faster.
Pharmexcil and companies like DM Pharma Global are improving digital services so that buyers and sellers can connect easily and do business smoothly across the world.
3️⃣ Global Partnerships
India is also working with other countries to build stronger relationships. The ongoing India-UK Free Trade Agreement (FTA) is one such example. This agreement will help in:
✔ Improving supply chains
✔ Making affordable medicines more accessible
✔ Attracting foreign investment in research and manufacturing
Pharma companies like DM Pharma Global are also trusted as reliable pharma contract manufacturing company partners. They help other companies make high-quality medicines at the right cost.
What Is the Future Plan?
The Indian government has set a big goal: a trillion-dollar trade target for the pharma sector. This means making India a global leader in affordable, top-quality medicines.
To achieve this, the industry is focusing on:
✔ Expanding production capacity so we can make more medicines
✔ Encouraging innovation so we can create new and better treatments
✔ Supporting monopoly franchise models to help small business owners and distributors
✔ Building better infrastructure to ensure medicines reach every corner of the world
Platforms like iPHEX 2025, set for September, will show India’s strength in pharma to the world and bring in new opportunities for partnership and trade.
Conclusion
India’s pharma exports in May 2025 are proof that we are moving in the right direction. With $4,961 million in exports, a 7.38% rise, and growing global trust, the future looks bright.
DM Pharma Global is proud to be part of this success. Whether you are looking for a monopoly medicine company in India or a trusted pharma contract manufacturing company, DM Pharma Global is here to support your business journey.
By focusing on clean manufacturing, digital growth, and global partnerships, India is all set to become a leader in pharmaceuticals, serving both health and humanity across the world.